Pharmaceuticals in Brazil
Pharmaceuticals in Brazil
SUMMARY
Pharmaceuticals in Brazil industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in Brazil industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Brazilian pharmaceuticals market had total revenues of $29,550.0m in 2019, representing a compound annual growth rate (CAGR) of 6.6% between 2015 and 2019.
- Drug registration in Brazil with a new electronic system has been introduced under which drugs can be approved within six months, rather than up to two years, which has helped drive market growth.
- The Brazilian pharmaceutical market is one of the top emerging markets globally. In terms of revenue it is the seventh largest market in the world and the largest in Latin America.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Brazil
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Brazil
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Brazil pharmaceuticals market with five year forecasts
- What was the size of the Brazil pharmaceuticals market by value in 2019?
- What will be the size of the Brazil pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the Brazil pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in Brazil's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. How does government regulation impact leading players?
7.6. What has been the rationale behind recent M&A activity?
8 COMPANY PROFILES
8.1. Sanofi SA
8.2. EMS Sigma Pharma
8.3. Ache Laboratorios Farmaceuticos SA
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. How does government regulation impact leading players?
7.6. What has been the rationale behind recent M&A activity?
8 COMPANY PROFILES
8.1. Sanofi SA
8.2. EMS Sigma Pharma
8.3. Ache Laboratorios Farmaceuticos SA
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Brazil pharmaceuticals market value: $ billion, 2015-19
Table 2: Brazil pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Brazil pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Brazil pharmaceuticals market share: % share, by value, 2019
Table 5: Sanofi SA: key facts
Table 6: Sanofi SA: Annual Financial Ratios
Table 7: Sanofi SA: Key Employees
Table 8: Sanofi SA: Key Employees Continued
Table 9: EMS Sigma Pharma: key facts
Table 10: EMS Sigma Pharma: Key Employees
Table 11: Ache Laboratorios Farmaceuticos SA: key facts
Table 12: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 13: Brazil size of population (million), 2015-19
Table 14: Brazil gdp (constant 2005 prices, $ billion), 2015-19
Table 15: Brazil gdp (current prices, $ billion), 2015-19
Table 16: Brazil inflation, 2015-19
Table 17: Brazil consumer price index (absolute), 2015-19
Table 18: Brazil exchange rate, 2015-19
Table 1: Brazil pharmaceuticals market value: $ billion, 2015-19
Table 2: Brazil pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Brazil pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Brazil pharmaceuticals market share: % share, by value, 2019
Table 5: Sanofi SA: key facts
Table 6: Sanofi SA: Annual Financial Ratios
Table 7: Sanofi SA: Key Employees
Table 8: Sanofi SA: Key Employees Continued
Table 9: EMS Sigma Pharma: key facts
Table 10: EMS Sigma Pharma: Key Employees
Table 11: Ache Laboratorios Farmaceuticos SA: key facts
Table 12: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 13: Brazil size of population (million), 2015-19
Table 14: Brazil gdp (constant 2005 prices, $ billion), 2015-19
Table 15: Brazil gdp (current prices, $ billion), 2015-19
Table 16: Brazil inflation, 2015-19
Table 17: Brazil consumer price index (absolute), 2015-19
Table 18: Brazil exchange rate, 2015-19
LIST OF FIGURES
Figure 1: Brazil pharmaceuticals market value: $ billion, 2015-19
Figure 2: Brazil pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Brazil pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Brazil, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Brazil, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Brazil, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2019
Figure 10: Brazil pharmaceuticals market share: % share, by value, 2019
Figure 1: Brazil pharmaceuticals market value: $ billion, 2015-19
Figure 2: Brazil pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Brazil pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Brazil, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Brazil, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Brazil, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2019
Figure 10: Brazil pharmaceuticals market share: % share, by value, 2019
